凯立新材(688269.SH)：催化剂产品可用于创新药研制、医药中间体和原料药生产

Group 1 - The core viewpoint of the article is that Kaili New Materials (688269.SH) has developed catalyst products that can be utilized in the research and development of innovative drugs, as well as in the production of pharmaceutical intermediates and active pharmaceutical ingredients [1] - By the first half of 2025, the revenue from the pharmaceutical sector for the company’s catalyst products is expected to account for 40.51% of total revenue [1]